Ángel Galindo

Feb 21, 2025 | dialnet.unirioja.es | Pedro Lago |Ángel Galindo |Helenio Ferrer |Ángel Goyenechea

Ayuda Buscar en la ayuda Buscar en la ayuda Casos de poliomielitis paralítica asociada a la vacuna oral antipoliomielítica en Cuba (1963-2006) Pedro Más Lago [1] ; Helenio Ferrer [1] ; Ángel Goyenechea [1] ; Ángel Galindo [1] ; Luis Sarmiento [1] ; Magilé Fonseca [1] ; Luis Morier [1] ; Rosa Palomera [1] [1] Instituto de Medicina Tropical Pedro Kourí Localización: Revista Cubana de Higiene y Epidemiología, ISSN-e 1561-3003, Vol. 46, Nº. 2, 2008 Idioma: español Títulos paralelos: Cases of...

Feb 10, 2025 | dialnet.unirioja.es | Ángel Calvo Valcárcel |Ángel Galindo |Calvo Valcárcel |Carrasco Martín

Ayuda Buscar en la ayuda Buscar en la ayuda Estrategias innovadoras para optimizar la fertilización del cereal de invierno: resultados de ensayos "on farm" Ángel Calvo [1] ; Isarael Carrasco [1] ; Ángel Maresma [1] [1] Departamento I+D. Eurochem Agro Iberia, S.L. Localización: Tierras: Agricultura, ISSN-e 2696-3752, ISSN 1889-0776, Nº. 336, 2025, págs.

Jan 16, 2025 | thepharmaletter.com | Ángel Galindo

Despite the strategies and programs that have been implemented to bring effective and equitable access to new medicines and technologies that provide equal or similar opportunities for citizens, regardless of their country, the reality is very different in Latin America, writes The Pharma Letter's local correspondent.

Nov 28, 2024 | thepharmaletter.com | Ángel Galindo

The waiting time for Latin American patients with cancer, central nervous system disorders or rare diseases can take up to 4.75 years from the time a drug receives approval from global health authorities such as the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA), until it is approved by their local authority and is available on the market, writes The Pharma Letter's local correspondent.

Nov 7, 2024 | thepharmaletter.com | Ángel Galindo

According to UNICEF's State of the World's Children 2023 report, in Latin America and the Caribbean, 6.8 million children did not benefit from vaccination during the time of the pandemic and in the following two years, progress has not been as expected either. For this reason, one of the great challenges is to raise vaccination rates to the levels they had before COVID-19, writes The Pharma Letter's local correspondent.